Ester Local Anesthetic [EPC]

Ester Local Anesthetic [EPC] was reported 49968 times

Drugs of the Ester Local Anesthetic [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 628 0.5913
1 INSPIRATORY CAPACITY DECREASED 88 0.3177
2 SLEEP DISORDER THERAPY 61 0.3081
3 APPENDICOLITH 89 0.2300
4 ANALGESIC THERAPY 61 0.1900
5 DRUG THERAPY 61 0.1799
6 TOXIC ANTERIOR SEGMENT SYNDROME 181 0.1659
7 MATERNAL EXPOSURE DURING DELIVERY 157 0.1584
8 INFUSION SITE DISCHARGE 220 0.1254
9 METHAEMOGLOBINAEMIA 248 0.1070
10 LAGOPHTHALMOS 43 0.1051
11 INFUSION SITE MASS 97 0.0892
12 INFUSION SITE URTICARIA 59 0.0881
13 INFUSION SITE BRUISING 179 0.0828
14 INFUSION SITE PRURITUS 255 0.0807
15 INFUSION SITE HAEMORRHAGE 240 0.0729
16 CAUDA EQUINA SYNDROME 50 0.0651
17 PROCEDURAL HYPOTENSION 52 0.0611
18 INFUSION SITE RASH 83 0.0605
19 INFUSION SITE SWELLING 374 0.0594
20 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 63 0.0593
21 ANAESTHETIC COMPLICATION NEUROLOGICAL 51 0.0563
22 INFUSION SITE DISCOMFORT 58 0.0559
23 ANAESTHETIC COMPLICATION 145 0.0539
24 INFUSION SITE NODULE 50 0.0520
25 HYPOPYON 43 0.0519
26 INFUSION SITE WARMTH 59 0.0481
27 KOUNIS SYNDROME 109 0.0480
28 NEPHROGENIC ANAEMIA 210 0.0453
29 INFUSION SITE IRRITATION 57 0.0444
30 HYPERPARATHYROIDISM SECONDARY 111 0.0443
31 HYPERPHOSPHATAEMIA 94 0.0437
32 DEVICE INFUSION ISSUE 108 0.0435
33 INFUSION SITE ERYTHEMA 364 0.0431
34 INFUSION SITE PAIN 546 0.0423
35 INCORRECT DRUG ADMINISTRATION RATE 178 0.0418
36 INFUSION SITE EXTRAVASATION 248 0.0398
37 HYPERTHERMIA MALIGNANT 57 0.0383
38 MULTIPLE ALLERGIES 295 0.0376
39 ADMINISTRATION SITE PAIN 43 0.0373
40 VASOPLEGIA SYNDROME 61 0.0372
41 RETINAL VASCULITIS 44 0.0369
42 BLOOD PHOSPHORUS INCREASED 92 0.0337
43 INSURANCE ISSUE 508 0.0332
44 CORNEAL OEDEMA 68 0.0303
45 INFUSION SITE REACTION 90 0.0301
46 SEASONAL ALLERGY 419 0.0296
47 PULSELESS ELECTRICAL ACTIVITY 121 0.0289
48 INFUSION SITE INDURATION 40 0.0270
49 TOTAL LUNG CAPACITY DECREASED 42 0.0263
50 VENTRICULAR FIBRILLATION 278 0.0250
51 REBOUND ACID HYPERSECRETION 75 0.0248
52 DERMATITIS CONTACT 277 0.0243
53 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 78 0.0235
54 OBSTRUCTION 91 0.0228
55 RESPIRATORY TRACT INFECTION VIRAL 53 0.0227
56 STRESS CARDIOMYOPATHY 131 0.0225
57 VENTRICULAR TACHYCARDIA 350 0.0212
58 IRON DEFICIENCY 94 0.0209
59 LUNG OPACITY 55 0.0208
60 PARAPLEGIA 60 0.0208
61 END STAGE RENAL DISEASE 377 0.0206
62 PULSE ABSENT 96 0.0202
63 ANAPHYLACTIC SHOCK 519 0.0201
64 POOR VENOUS ACCESS 204 0.0197
65 EAR INFECTION 518 0.0194
66 RESPIRATORY TRACT INFECTION 504 0.0193
67 SINUSITIS 1951 0.0190
68 CHRONIC SINUSITIS 71 0.0189
69 TYPE I HYPERSENSITIVITY 65 0.0185
70 INGROWING NAIL 43 0.0182
71 AORTIC STENOSIS 61 0.0175
72 GENERALISED TONIC-CLONIC SEIZURE 289 0.0174
73 STATUS EPILEPTICUS 197 0.0174
74 VENTRICULAR HYPOKINESIA 56 0.0174
75 PRODUCT DISTRIBUTION ISSUE 160 0.0172
76 CARDIOGENIC SHOCK 244 0.0170
77 HYPOPHOSPHATAEMIA 125 0.0169
78 ANIMAL BITE 45 0.0169
79 ENDOPHTHALMITIS 100 0.0167
80 OTITIS MEDIA 55 0.0166
81 UPPER RESPIRATORY TRACT INFECTION 769 0.0166
82 APNOEA 127 0.0163
83 MYASTHENIA GRAVIS 130 0.0161
84 VASCULAR DEVICE INFECTION 73 0.0161
85 LUMBAR SPINAL STENOSIS 47 0.0161
86 HAEMODYNAMIC INSTABILITY 122 0.0160
87 RHINOVIRUS INFECTION 62 0.0159
88 SKIN ABRASION 75 0.0159
89 RETINAL ARTERY OCCLUSION 40 0.0158
90 CATHETER SITE PAIN 41 0.0158
91 PRODUCT ADHESION ISSUE 561 0.0157
92 BLOOD URIC ACID INCREASED 89 0.0154
93 STREPTOCOCCAL INFECTION 85 0.0153
94 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 78 0.0152
95 DEAFNESS NEUROSENSORY 50 0.0152
96 BUNDLE BRANCH BLOCK LEFT 64 0.0151
97 VENTRICULAR ARRHYTHMIA 55 0.0150
98 ANHEDONIA 393 0.0149
99 HYPERCAPNIA 45 0.0149
100 LARYNGOSPASM 40 0.0149
101 SKIN INFECTION 165 0.0147
102 ANAPHYLACTIC REACTION 802 0.0145
103 SINUS TACHYCARDIA 206 0.0145
104 RENAL INJURY 427 0.0144
105 STRIDOR 41 0.0139
106 GASTROENTERITIS VIRAL 249 0.0138
107 MULTI-ORGAN FAILURE 236 0.0136
108 ARTHRITIS BACTERIAL 56 0.0136
109 TENDERNESS 141 0.0135
110 APPENDICITIS 126 0.0135
111 ATELECTASIS 130 0.0134
112 PHARYNGITIS STREPTOCOCCAL 145 0.0134
113 PROCTALGIA 86 0.0134
114 MENINGITIS ASEPTIC 60 0.0134
115 BRONCHIECTASIS 90 0.0133
116 FEAR 355 0.0132
117 SPINAL CORD COMPRESSION 51 0.0131
118 PARADOXICAL DRUG REACTION 48 0.0130
119 VENTRICULAR EXTRASYSTOLES 134 0.0129
120 SPINAL OSTEOARTHRITIS 113 0.0128
121 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 65 0.0128
122 SKIN LACERATION 137 0.0126
123 RESPIRATORY DEPRESSION 153 0.0125
124 RESPIRATORY ACIDOSIS 49 0.0125
125 INTERVERTEBRAL DISC DEGENERATION 114 0.0123
126 TOOTH INFECTION 162 0.0123
127 LIVE BIRTH 101 0.0121
128 NYSTAGMUS 64 0.0120
129 GASTROINTESTINAL INFECTION 108 0.0120
130 HYPOXIA 424 0.0120
131 BACTERIAL INFECTION 224 0.0120
132 CARDIAC ARREST 987 0.0119
133 UNRESPONSIVE TO STIMULI 308 0.0119
134 PRODUCT ADMINISTRATION INTERRUPTED 93 0.0118
135 SINUS BRADYCARDIA 112 0.0116
136 BRONCHITIS 855 0.0115
137 NEUROTOXICITY 200 0.0114
138 BRADYCARDIA 601 0.0113
139 HORDEOLUM 49 0.0113
140 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 193 0.0112
141 HYPERLIPIDAEMIA 134 0.0112
142 ARTHRITIS INFECTIVE 52 0.0112
143 TROPONIN INCREASED 85 0.0112
144 DECUBITUS ULCER 91 0.0112
145 BREATH SOUNDS ABNORMAL 55 0.0111
146 NEURALGIA 271 0.0111
147 KIDNEY INFECTION 218 0.0111
148 RESPIRATORY SYNCYTIAL VIRUS INFECTION 96 0.0110
149 SINUS DISORDER 218 0.0110
150 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 97 0.0110
151 CHRONIC KIDNEY DISEASE 833 0.0110
152 BRAIN OEDEMA 138 0.0109
153 PNEUMONIA FUNGAL 43 0.0109
154 PSEUDOMONAS INFECTION 93 0.0108
155 VIRAL INFECTION 360 0.0108
156 MYDRIASIS 138 0.0107
157 TORSADE DE POINTES 84 0.0107
158 SENSORY LOSS 86 0.0107
159 EYE INFECTION 120 0.0106
160 POST PROCEDURAL INFECTION 86 0.0106
161 MENTAL STATUS CHANGES 292 0.0105
162 NORMAL NEWBORN 57 0.0105
163 PERIPHERAL VASCULAR DISORDER 54 0.0105
164 WEIGHT FLUCTUATION 108 0.0103
165 HYPERVOLAEMIA 51 0.0103
166 GLUCOSE TOLERANCE IMPAIRED 61 0.0103
167 TRIGEMINAL NEURALGIA 41 0.0102
168 BRONCHOSPASM 145 0.0102
169 CANDIDA INFECTION 171 0.0101
170 TOOTH ABSCESS 103 0.0101
171 PRE-EXISTING CONDITION IMPROVED 63 0.0101
172 FOOD POISONING 54 0.0101
173 PHARYNGITIS 125 0.0101
174 POST PROCEDURAL COMPLICATION 193 0.0100
175 IMMUNE THROMBOCYTOPENIA 46 0.0100
176 HEPARIN-INDUCED THROMBOCYTOPENIA 49 0.0099
177 CIRCULATORY COLLAPSE 169 0.0099
178 MYOCLONUS 118 0.0099
179 RHINITIS ALLERGIC 44 0.0099
180 STAPHYLOCOCCAL INFECTION 326 0.0099
181 INFUSION RELATED REACTION 655 0.0099
182 RALES 57 0.0098
183 HYPOAESTHESIA ORAL 147 0.0097
184 LEFT VENTRICULAR DYSFUNCTION 65 0.0097
185 CONCUSSION 74 0.0095
186 CYSTITIS 304 0.0095
187 LOCALISED INFECTION 230 0.0095
188 VARICOSE VEIN 49 0.0095
189 SKIN NECROSIS 49 0.0094
190 MENINGITIS 63 0.0094
191 CARDIOTOXICITY 84 0.0094
192 PROCEDURAL COMPLICATION 72 0.0094
193 DIVERTICULUM INTESTINAL 41 0.0094
194 ARTHROPOD BITE 68 0.0092
195 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 502 0.0091
196 ESCHERICHIA INFECTION 75 0.0091
197 FOOD ALLERGY 70 0.0091
198 RIB FRACTURE 185 0.0090
199 RENAL FAILURE 1190 0.0090
200 STAPHYLOCOCCAL SEPSIS 44 0.0089
201 SPINAL COLUMN STENOSIS 42 0.0089
202 URINARY TRACT INFECTION 1510 0.0088
203 ECONOMIC PROBLEM 134 0.0088
204 NERVE INJURY 98 0.0088
205 INJURY 619 0.0088
206 RENAL TUBULAR NECROSIS 86 0.0088
207 HYPERAESTHESIA 72 0.0088
208 ACUTE RESPIRATORY FAILURE 168 0.0087
209 VITREOUS FLOATERS 85 0.0086
210 CELLULITIS 435 0.0086
211 SUPRAVENTRICULAR TACHYCARDIA 82 0.0086
212 ATRIOVENTRICULAR BLOCK COMPLETE 57 0.0085
213 ROTATOR CUFF SYNDROME 108 0.0084
214 HAEMORRHOIDS 164 0.0084
215 SCIATICA 134 0.0084
216 FACIAL PAIN 75 0.0084
217 LIGAMENT SPRAIN 83 0.0084
218 COVID-19 PNEUMONIA 99 0.0084
219 ACUTE PULMONARY OEDEMA 47 0.0084
220 MIOSIS 67 0.0083
221 GINGIVITIS 45 0.0083
222 NERVE COMPRESSION 77 0.0083
223 IMPAIRED GASTRIC EMPTYING 113 0.0083
224 PRODUCTIVE COUGH 394 0.0082
225 LYMPHOEDEMA 57 0.0082
226 LIMB INJURY 222 0.0082
227 MUSCULOSKELETAL CHEST PAIN 126 0.0081
228 BEHAVIOUR DISORDER 44 0.0081
229 BENIGN PROSTATIC HYPERPLASIA 42 0.0081
230 GRAND MAL CONVULSION 75 0.0081
231 HYPOTENSION 1629 0.0081
232 FIBROMYALGIA 197 0.0081
233 MUSCLE STRAIN 70 0.0081
234 TACHYPNOEA 110 0.0081
235 ILLNESS 833 0.0081
236 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 44 0.0081
237 SCAR 138 0.0081
238 ORAL CANDIDIASIS 106 0.0080
239 IRON DEFICIENCY ANAEMIA 74 0.0080
240 POSTOPERATIVE WOUND INFECTION 54 0.0080
241 COVID-19 1400 0.0080
242 DRUG LEVEL INCREASED 132 0.0080
243 RESPIRATORY TRACT CONGESTION 126 0.0079
244 SKIN WARM 46 0.0079
245 UPPER-AIRWAY COUGH SYNDROME 65 0.0079
246 ECCHYMOSIS 54 0.0079
247 FACIAL PARALYSIS 67 0.0079
248 SPINAL PAIN 92 0.0078
249 THERAPY PARTIAL RESPONDER 122 0.0078
250 RENAL CYST 62 0.0078
251 HIATUS HERNIA 101 0.0078
252 HYPERKERATOSIS 43 0.0078
253 FOOT FRACTURE 147 0.0077
254 FAILURE TO THRIVE 40 0.0077
255 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 401 0.0077
256 OSTEOMYELITIS 139 0.0077
257 TACHYCARDIA 682 0.0077
258 EXOSTOSIS 70 0.0077
259 MULTIPLE ORGAN DYSFUNCTION SYNDROME 217 0.0077
260 CLOSTRIDIUM DIFFICILE COLITIS 81 0.0076
261 RETINAL HAEMORRHAGE 54 0.0076
262 ANAL INCONTINENCE 68 0.0076
263 FEBRILE NEUTROPENIA 500 0.0075
264 TOXICITY TO VARIOUS AGENTS 1265 0.0075
265 SLEEP APNOEA SYNDROME 143 0.0075
266 HAND FRACTURE 53 0.0075
267 COMPRESSION FRACTURE 40 0.0075
268 OSTEOPENIA 113 0.0074
269 INJECTION SITE DISCHARGE 40 0.0074
270 JOINT EFFUSION 51 0.0074
271 CYANOSIS 116 0.0074
272 SENSITIVE SKIN 54 0.0073
273 AUTOIMMUNE DISORDER 71 0.0073
274 SINUS CONGESTION 98 0.0072
275 DIPLOPIA 188 0.0072
276 ULCER 115 0.0072
277 CARPAL TUNNEL SYNDROME 101 0.0072
278 OXYGEN SATURATION DECREASED 405 0.0072
279 OBSTRUCTIVE AIRWAYS DISORDER 80 0.0072
280 PNEUMOTHORAX 114 0.0072
281 VITAMIN D DEFICIENCY 70 0.0072
282 CARDIOMEGALY 88 0.0071
283 PARAESTHESIA ORAL 103 0.0071
284 RESPIRATORY DISTRESS 197 0.0071
285 UNEVALUABLE EVENT 538 0.0071
286 EYELID PTOSIS 72 0.0071
287 BLOOD CALCIUM INCREASED 62 0.0071
288 INADEQUATE ANALGESIA 60 0.0071
289 SPINAL COMPRESSION FRACTURE 58 0.0070
290 POST-TRAUMATIC STRESS DISORDER 47 0.0070
291 BODY TEMPERATURE INCREASED 143 0.0070
292 INCONTINENCE 74 0.0070
293 HEREDITARY ANGIOEDEMA 75 0.0070
294 GOUT 125 0.0070
295 FLANK PAIN 65 0.0069
296 MASS 96 0.0069
297 ASPIRATION 75 0.0068
298 ENCEPHALOPATHY 168 0.0068
299 BURSITIS 83 0.0068
300 DYSARTHRIA 257 0.0068
301 SMALL INTESTINAL OBSTRUCTION 84 0.0068
302 NECK PAIN 381 0.0068
303 INTERVERTEBRAL DISC PROTRUSION 149 0.0068
304 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 42 0.0068
305 PREMATURE DELIVERY 108 0.0068
306 SPINAL DISORDER 64 0.0068
307 PNEUMONIA BACTERIAL 62 0.0067
308 IMPAIRED QUALITY OF LIFE 97 0.0067
309 HYPERCHOLESTEROLAEMIA 65 0.0067
310 SEROTONIN SYNDROME 129 0.0067
311 MALNUTRITION 75 0.0067
312 BRAIN FOG 105 0.0067
313 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 52 0.0067
314 ORAL DISORDER 49 0.0067
315 WOUND INFECTION 73 0.0067
316 FUNGAL INFECTION 222 0.0067
317 WRONG PRODUCT ADMINISTERED 45 0.0067
318 SEPSIS 740 0.0066
319 JOINT DISLOCATION 70 0.0066
320 PULMONARY MASS 98 0.0066
321 DRUG TOXICITY 89 0.0065
322 THERAPY NON-RESPONDER 293 0.0065
323 LARYNGEAL OEDEMA 40 0.0065
324 BACTERAEMIA 77 0.0065
325 DIVERTICULUM 46 0.0065
326 PULMONARY OEDEMA 289 0.0064
327 BODY HEIGHT DECREASED 69 0.0064
328 MUSCULOSKELETAL DISCOMFORT 111 0.0064
329 HYPOALBUMINAEMIA 50 0.0064
330 NEPHROPATHY 60 0.0064
331 TRICUSPID VALVE INCOMPETENCE 51 0.0064
332 PNEUMONIA ASPIRATION 160 0.0064
333 PULMONARY CONGESTION 84 0.0064
334 HERPES ZOSTER 366 0.0064
335 CLOSTRIDIUM DIFFICILE INFECTION 139 0.0064
336 INFLUENZA 710 0.0064
337 PNEUMONIA 2057 0.0063
338 OEDEMA 344 0.0063
339 BLOOD PRESSURE ABNORMAL 126 0.0063
340 PHARYNGEAL SWELLING 62 0.0063
341 SPUTUM DISCOLOURED 60 0.0063
342 MIGRAINE 603 0.0063
343 DIVERTICULITIS 175 0.0063
344 MOTOR DYSFUNCTION 64 0.0063
345 JOINT INJURY 134 0.0063
346 POOR QUALITY SLEEP 135 0.0063
347 PLEURAL EFFUSION 381 0.0063
348 SHOCK 144 0.0063
349 CARDIO-RESPIRATORY ARREST 261 0.0062
350 RESPIRATION ABNORMAL 43 0.0062
351 LUNG INFILTRATION 55 0.0062
352 RESPIRATORY FAILURE 454 0.0062
353 DELIRIUM 216 0.0062
354 RHINITIS 50 0.0062
355 ACCIDENT 74 0.0062
356 BRAIN INJURY 62 0.0062
357 CONTUSION 595 0.0062
358 UROSEPSIS 57 0.0062
359 EAR PAIN 120 0.0062
360 ORAL PAIN 138 0.0062
361 HAEMATOCRIT DECREASED 122 0.0061
362 CYTOKINE RELEASE SYNDROME 123 0.0061
363 RESPIRATORY ARREST 169 0.0061
364 BLOOD PRESSURE DECREASED 406 0.0061
365 BLINDNESS TRANSIENT 45 0.0061
366 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1099 0.0061
367 SPINAL OPERATION 75 0.0061
368 PARALYSIS 87 0.0061
369 EYE MOVEMENT DISORDER 41 0.0060
370 ASCITES 176 0.0060
371 CONJUNCTIVITIS 111 0.0060
372 BACK INJURY 65 0.0060
373 ACUTE KIDNEY INJURY 914 0.0060
374 PAPULE 42 0.0060
375 EMPHYSEMA 60 0.0059
376 APHTHOUS ULCER 46 0.0059
377 NEPHROLITHIASIS 272 0.0059
378 BLOOD ALBUMIN DECREASED 47 0.0059
379 MITRAL VALVE INCOMPETENCE 67 0.0059
380 PRODUCT DOSE OMISSION ISSUE 1739 0.0059
381 PELVIC FRACTURE 46 0.0059
382 ATAXIA 70 0.0059
383 METABOLIC ACIDOSIS 188 0.0059
384 PROCEDURAL PAIN 163 0.0059
385 EXTRASYSTOLES 41 0.0059
386 EYE INFLAMMATION 56 0.0059
387 ELECTROCARDIOGRAM QT PROLONGED 211 0.0059
388 MICTURITION URGENCY 67 0.0059
389 NASOPHARYNGITIS 1081 0.0059
390 BACK PAIN 1360 0.0058
391 RIGHT VENTRICULAR FAILURE 41 0.0058
392 BACK DISORDER 95 0.0058
393 INABILITY TO AFFORD MEDICATION 58 0.0058
394 ANKLE FRACTURE 90 0.0058
395 SKIN ULCER 150 0.0058
396 LEUKOCYTOSIS 105 0.0058
397 LOW BIRTH WEIGHT BABY 46 0.0058
398 DYSPNOEA EXERTIONAL 218 0.0058
399 SEIZURE 668 0.0058
400 HOSPICE CARE 57 0.0058
401 OSTEOARTHRITIS 244 0.0057
402 NODULE 75 0.0057
403 APHONIA 80 0.0057
404 PULMONARY HYPERTENSION 119 0.0057
405 BLOOD PRESSURE DIASTOLIC DECREASED 42 0.0057
406 SPINAL FRACTURE 114 0.0057
407 OSTEOPOROSIS 234 0.0057
408 INFECTION 822 0.0057
409 JOINT RANGE OF MOTION DECREASED 76 0.0057
410 PREMATURE BABY 170 0.0056
411 BLADDER DISORDER 56 0.0056
412 DEPRESSED LEVEL OF CONSCIOUSNESS 223 0.0056
413 DISABILITY 111 0.0056
414 MAJOR DEPRESSION 41 0.0056
415 HYDRONEPHROSIS 42 0.0056
416 DEVICE RELATED INFECTION 86 0.0056
417 GROIN PAIN 49 0.0056
418 CHILLS 654 0.0056
419 ATRIOVENTRICULAR BLOCK 43 0.0056
420 RETINAL DETACHMENT 51 0.0055
421 PAIN IN JAW 157 0.0055
422 SWELLING 518 0.0055
423 DENTAL CARIES 61 0.0055
424 HYPERTHERMIA 42 0.0055
425 TUBULOINTERSTITIAL NEPHRITIS 103 0.0055
426 ORAL HERPES 107 0.0055
427 TOOTHACHE 99 0.0055
428 HEAD INJURY 173 0.0055
429 RENAL FAILURE CHRONIC 42 0.0055
430 MUSCLE RIGIDITY 65 0.0054
431 ARTERIOSCLEROSIS 51 0.0054
432 RESPIRATORY DISORDER 162 0.0054
433 LOWER RESPIRATORY TRACT INFECTION 246 0.0054
434 ATRIAL FIBRILLATION 525 0.0054
435 ATRIAL FLUTTER 43 0.0054
436 APPLICATION SITE PAIN 118 0.0054
437 TOOTH DISORDER 119 0.0053
438 EJECTION FRACTION DECREASED 83 0.0053
439 BLOOD MAGNESIUM DECREASED 46 0.0053
440 ABSCESS 85 0.0053
441 RENAL FAILURE ACUTE 226 0.0053
442 ACUTE CORONARY SYNDROME 44 0.0053
443 PURPURA 47 0.0053
444 BLOOD IRON DECREASED 63 0.0053
445 BLOOD POTASSIUM DECREASED 159 0.0053
446 HYPOKALAEMIA 244 0.0053
447 SUBSTANCE ABUSE 43 0.0053
448 GASTROOESOPHAGEAL REFLUX DISEASE 424 0.0053
449 DIZZINESS POSTURAL 51 0.0053
450 WRIST FRACTURE 63 0.0053
451 PAIN 3222 0.0052
452 HEART RATE DECREASED 184 0.0052
453 FALL 1743 0.0052
454 OROPHARYNGEAL PAIN 483 0.0052
455 LOSS OF CONSCIOUSNESS 668 0.0052
456 MUSCLE TWITCHING 120 0.0052
457 BLOOD UREA INCREASED 87 0.0052
458 HEMIPARESIS 88 0.0052
459 HEPATOMEGALY 51 0.0052
460 MYOCARDIAL ISCHAEMIA 59 0.0052
461 ELECTROLYTE IMBALANCE 60 0.0052
462 ANXIETY 1468 0.0052
463 PULMONARY THROMBOSIS 56 0.0051
464 HYPERTENSIVE CRISIS 57 0.0051
465 MUSCLE TIGHTNESS 83 0.0051
466 UPPER LIMB FRACTURE 102 0.0051
467 CATARACT 304 0.0051
468 HYPOMAGNESAEMIA 71 0.0051
469 IRRITABLE BOWEL SYNDROME 109 0.0051
470 NEUTROPHIL COUNT INCREASED 52 0.0051
471 PYELONEPHRITIS 44 0.0051
472 LETHARGY 292 0.0051
473 ILEUS 63 0.0051
474 POST PROCEDURAL HAEMORRHAGE 59 0.0051
475 HYPONATRAEMIA 285 0.0051
476 PHOTOPHOBIA 95 0.0050
477 MYOSITIS 45 0.0050
478 STOMATITIS 304 0.0050
479 CARDIOMYOPATHY 74 0.0050
480 INTENTIONAL PRODUCT USE ISSUE 437 0.0050
481 OROPHARYNGEAL DISCOMFORT 45 0.0050
482 BLOOD CALCIUM DECREASED 56 0.0050
483 HAEMATOMA 129 0.0050
484 DRUG INTERACTION 788 0.0050
485 FOOT DEFORMITY 55 0.0050
486 URINARY INCONTINENCE 147 0.0050
487 BONE DISORDER 90 0.0049
488 GENERALISED OEDEMA 61 0.0049
489 EMOTIONAL DISTRESS 593 0.0049
490 LYMPHADENOPATHY 173 0.0049
491 NEUROPATHY PERIPHERAL 464 0.0049
492 HAEMOPTYSIS 136 0.0049
493 PALLOR 132 0.0048
494 ACCIDENTAL OVERDOSE 177 0.0048
495 CYST 60 0.0048
496 BLOOD PRESSURE INCREASED 739 0.0048
497 URINARY RETENTION 161 0.0048
498 HYPERTENSION 1021 0.0048
499 LIMB DISCOMFORT 149 0.0048
500 SUBARACHNOID HAEMORRHAGE 49 0.0048
501 OCULAR DISCOMFORT 54 0.0048
502 COMA 229 0.0048
503 PYREXIA 1661 0.0048
504 TINNITUS 220 0.0048
505 COUGH 1338 0.0048
506 DISCOMFORT 291 0.0048
507 BLOOD TEST ABNORMAL 67 0.0048
508 NASAL CONGESTION 280 0.0048
509 HYPERKALAEMIA 167 0.0048
510 OESOPHAGITIS 52 0.0048
511 LYMPHOCYTE COUNT DECREASED 84 0.0047
512 PSYCHOLOGICAL TRAUMA 41 0.0047
513 RESTLESS LEGS SYNDROME 86 0.0047
514 TOOTH FRACTURE 52 0.0047
515 VISUAL ACUITY REDUCED 156 0.0047
516 INTRAOCULAR PRESSURE INCREASED 60 0.0047
517 ROAD TRAFFIC ACCIDENT 196 0.0047
518 BASAL CELL CARCINOMA 73 0.0047
519 INCREASED TENDENCY TO BRUISE 43 0.0047
520 BLOOD SODIUM DECREASED 88 0.0047
521 MUCOSAL INFLAMMATION 122 0.0047
522 COLD SWEAT 82 0.0046
523 PRESYNCOPE 113 0.0046
524 SCRATCH 49 0.0046
525 CARDIAC MURMUR 40 0.0046
526 QUALITY OF LIFE DECREASED 62 0.0046
527 WHEEZING 274 0.0046
528 DISSEMINATED INTRAVASCULAR COAGULATION 65 0.0046
529 EYE PAIN 260 0.0046
530 HYPOTONIA 46 0.0046
531 EXPOSURE DURING PREGNANCY 286 0.0046
532 DEFORMITY 43 0.0046
533 HEADACHE 2869 0.0046
534 LIVER FUNCTION TEST INCREASED 98 0.0046
535 RESTLESSNESS 167 0.0046
536 COAGULOPATHY 76 0.0046
537 RENAL IMPAIRMENT 383 0.0046
538 SEPTIC SHOCK 198 0.0045
539 ANGIOEDEMA 201 0.0045
540 DERMATITIS ALLERGIC 57 0.0045
541 BLOOD URINE PRESENT 86 0.0045
542 DEHYDRATION 604 0.0045
543 RENAL PAIN 48 0.0045
544 PRODUCT USE IN UNAPPROVED INDICATION 1122 0.0045
545 EYE DISCHARGE 47 0.0045
546 CHROMATURIA 102 0.0045
547 HALLUCINATION, VISUAL 95 0.0045
548 HERNIA 87 0.0045
549 CONSTIPATION 981 0.0045
550 TOXIC EPIDERMAL NECROLYSIS 68 0.0045
551 LOWER LIMB FRACTURE 86 0.0045
552 WOUND 125 0.0045
553 HEART RATE INCREASED 442 0.0045
554 DYSURIA 164 0.0045
555 FULL BLOOD COUNT ABNORMAL 47 0.0044
556 NEOPLASM 51 0.0044
557 GASTROINTESTINAL DISORDER 397 0.0044
558 ABDOMINAL DISTENSION 461 0.0044
559 HYPOTHYROIDISM 141 0.0044
560 HYPOAESTHESIA 660 0.0044
561 COMPLICATION ASSOCIATED WITH DEVICE 64 0.0044
562 THROMBOSIS 354 0.0044
563 ERYTHEMA MULTIFORME 41 0.0044
564 MATERNAL EXPOSURE DURING PREGNANCY 391 0.0044
565 APHASIA 132 0.0044
566 SQUAMOUS CELL CARCINOMA 41 0.0044
567 PERIPHERAL SWELLING 670 0.0043
568 FLUID RETENTION 221 0.0043
569 RED BLOOD CELL COUNT DECREASED 124 0.0043
570 SKIN DISCOLOURATION 198 0.0043
571 BURNING SENSATION 302 0.0043
572 CONFUSIONAL STATE 696 0.0043
573 TRANSFUSION 45 0.0043
574 BLOOD CHOLESTEROL INCREASED 200 0.0043
575 MOUTH ULCERATION 90 0.0043
576 CHEST PAIN 791 0.0043
577 EPISTAXIS 319 0.0043
578 SOMNOLENCE 858 0.0043
579 NERVOUS SYSTEM DISORDER 133 0.0043
580 SWOLLEN TONGUE 133 0.0043
581 GLAUCOMA 82 0.0043
582 CHEST DISCOMFORT 435 0.0042
583 ACUTE RESPIRATORY DISTRESS SYNDROME 75 0.0042
584 ASTHMA 478 0.0042
585 NEEDLE ISSUE 123 0.0042
586 ARTHRITIS 331 0.0042
587 HEART RATE IRREGULAR 95 0.0042
588 INFLUENZA LIKE ILLNESS 346 0.0042
589 TENDONITIS 65 0.0042
590 WHITE BLOOD CELL COUNT INCREASED 161 0.0042
591 SLEEP DISORDER 296 0.0042
592 DEVICE OCCLUSION 59 0.0042
593 TASTE DISORDER 85 0.0042
594 ANAEMIA 799 0.0042
595 MUSCULAR WEAKNESS 475 0.0042
596 DYSTONIA 81 0.0042
597 DRY MOUTH 338 0.0042
598 SARS-COV-2 TEST POSITIVE 55 0.0042
599 ARRHYTHMIA 197 0.0042
600 VERTIGO 253 0.0041
601 APPLICATION SITE RASH 57 0.0041
602 OEDEMA PERIPHERAL 504 0.0041
603 EATING DISORDER 88 0.0041
604 TENDON RUPTURE 51 0.0041
605 WEIGHT DECREASED 1153 0.0041
606 SYNCOPE 412 0.0041
607 IMPAIRED HEALING 135 0.0041
608 PULMONARY EMBOLISM 390 0.0041
609 SPEECH DISORDER 215 0.0041
610 ACUTE MYOCARDIAL INFARCTION 121 0.0041
611 MACULAR DEGENERATION 49 0.0041
612 EAR DISCOMFORT 42 0.0041
613 DYSPHAGIA 388 0.0041
614 LIP SWELLING 136 0.0041
615 LUNG DISORDER 200 0.0041
616 MUSCULOSKELETAL PAIN 213 0.0041
617 COLITIS 154 0.0041
618 AGITATION 298 0.0041
619 DYSKINESIA 164 0.0040
620 NIGHT SWEATS 130 0.0040
621 PETECHIAE 42 0.0040
622 HAIR COLOUR CHANGES 50 0.0040
623 VOMITING 1889 0.0040
624 PAIN IN EXTREMITY 1181 0.0040
625 FATIGUE 3117 0.0040
626 BLINDNESS 163 0.0040
627 SECRETION DISCHARGE 50 0.0040
628 RHINORRHOEA 257 0.0040
629 FACE OEDEMA 67 0.0040
630 DYSPHONIA 232 0.0040
631 SKIN DISORDER 132 0.0040
632 THYROID DISORDER 61 0.0040
633 TREMOR 655 0.0039
634 MENTAL DISORDER 171 0.0039
635 DYSPNOEA 2223 0.0039
636 GALLBLADDER DISORDER 70 0.0039
637 BLISTER 220 0.0039
638 BLOOD PRESSURE FLUCTUATION 94 0.0039
639 NAUSEA 3099 0.0039
640 HEAD DISCOMFORT 69 0.0039
641 DRUG INTOLERANCE 376 0.0039
642 BLOOD POTASSIUM INCREASED 63 0.0039
643 FEELING COLD 108 0.0039
644 TEMPERATURE INTOLERANCE 40 0.0039
645 SWELLING FACE 252 0.0039
646 SKIN LESION 106 0.0039
647 LUNG INFECTION 60 0.0039
648 PRODUCT ADMINISTRATION ERROR 78 0.0039
649 TOOTH EXTRACTION 48 0.0039
650 APPLICATION SITE ERYTHEMA 101 0.0038
651 CHOLECYSTECTOMY 44 0.0038
652 PERICARDIAL EFFUSION 89 0.0038
653 RETCHING 82 0.0038
654 CHOLELITHIASIS 126 0.0038
655 PRODUCT AVAILABILITY ISSUE 87 0.0038
656 PRODUCT USE ISSUE 718 0.0038
657 HYPOKINESIA 55 0.0038
658 CHOLECYSTITIS 45 0.0038
659 BALANCE DISORDER 326 0.0038
660 DERMATITIS 79 0.0038
661 SCAB 43 0.0038
662 PULMONARY FIBROSIS 72 0.0037
663 MUSCLE SPASMS 687 0.0037
664 BLOOD PRESSURE SYSTOLIC INCREASED 73 0.0037
665 ALTERED STATE OF CONSCIOUSNESS 81 0.0037
666 HAEMATURIA 128 0.0037
667 BEDRIDDEN 49 0.0037
668 URTICARIA 624 0.0037
669 PARAESTHESIA 586 0.0037
670 BREAST CANCER METASTATIC 40 0.0037
671 GASTRITIS 98 0.0037
672 MUSCULOSKELETAL STIFFNESS 325 0.0037
673 MUSCLE ATROPHY 47 0.0037
674 DISORIENTATION 147 0.0037
675 RED BLOOD CELL SEDIMENTATION RATE INCREASED 41 0.0037
676 DECREASED APPETITE 860 0.0037
677 DYSSTASIA 108 0.0037
678 PRODUCT QUALITY ISSUE 501 0.0037
679 FULL BLOOD COUNT DECREASED 74 0.0037
680 DEEP VEIN THROMBOSIS 238 0.0037
681 MUSCLE SPASTICITY 45 0.0037
682 SNEEZING 82 0.0037
683 HEPATIC STEATOSIS 68 0.0036
684 INJECTION SITE EXTRAVASATION 45 0.0036
685 PRODUCT DOSE OMISSION IN ERROR 103 0.0036
686 METASTASES TO LUNG 42 0.0036
687 PHOTOSENSITIVITY REACTION 60 0.0036
688 ADRENAL INSUFFICIENCY 44 0.0036
689 ERYTHEMA 745 0.0036
690 THROAT TIGHTNESS 98 0.0036
691 GAIT INABILITY 121 0.0036
692 SKIN REACTION 51 0.0036
693 BONE DENSITY DECREASED 113 0.0036
694 HYPERSOMNIA 103 0.0036
695 PULMONARY ARTERIAL HYPERTENSION 52 0.0036
696 TRANSIENT ISCHAEMIC ATTACK 121 0.0036
697 POISONING 45 0.0036
698 ABDOMINAL PAIN 833 0.0036
699 DRUG EFFECT LESS THAN EXPECTED 53 0.0036
700 HIP FRACTURE 115 0.0036
701 C-REACTIVE PROTEIN INCREASED 130 0.0036
702 INFLAMMATION 184 0.0036
703 ARTHROPATHY 198 0.0036
704 SEDATION 93 0.0035
705 MEDICATION ERROR 197 0.0035
706 ASPARTATE AMINOTRANSFERASE INCREASED 188 0.0035
707 SURGERY 207 0.0035
708 DEPRESSION 803 0.0035
709 GINGIVAL BLEEDING 48 0.0035
710 OBESITY 56 0.0035
711 PERICARDITIS 59 0.0035
712 DIABETES MELLITUS 267 0.0035
713 FEEDING DISORDER 71 0.0035
714 PERIPHERAL COLDNESS 48 0.0035
715 IMMUNE SYSTEM DISORDER 46 0.0035
716 PRODUCT PRESCRIBING ISSUE 76 0.0035
717 DIZZINESS 1739 0.0035
718 COGNITIVE DISORDER 162 0.0035
719 RECTAL HAEMORRHAGE 149 0.0035
720 CORONARY ARTERY DISEASE 105 0.0035
721 RASH MACULO-PAPULAR 77 0.0035
722 MADAROSIS 40 0.0034
723 EYELID OEDEMA 40 0.0034
724 HAIR TEXTURE ABNORMAL 46 0.0034
725 GAIT DISTURBANCE 658 0.0034
726 SKIN CANCER 74 0.0034
727 PANCYTOPENIA 192 0.0034
728 INTENTIONAL DOSE OMISSION 97 0.0034
729 BONE PAIN 199 0.0034
730 PREGNANCY 68 0.0034
731 HYPERHIDROSIS 436 0.0034
732 BLOOD ALKALINE PHOSPHATASE INCREASED 84 0.0034
733 THROAT IRRITATION 151 0.0034
734 HYPERSENSITIVITY 624 0.0034
735 PRODUCT PREPARATION ERROR 69 0.0034
736 JOINT STIFFNESS 88 0.0034
737 METASTASES TO BONE 55 0.0033
738 ASTHENIA 1258 0.0033
739 VISION BLURRED 459 0.0033
740 DRUG ABUSE 278 0.0033
741 AMNESIA 217 0.0033
742 METASTASES TO CENTRAL NERVOUS SYSTEM 43 0.0033
743 BLOOD BILIRUBIN INCREASED 90 0.0033
744 ARTHRALGIA 1384 0.0033
745 INCORRECT PRODUCT ADMINISTRATION DURATION 72 0.0033
746 LACRIMATION INCREASED 100 0.0033
747 MENTAL IMPAIRMENT 80 0.0033
748 RASH PRURITIC 178 0.0033
749 ACTIVITIES OF DAILY LIVING IMPAIRED 65 0.0033
750 HAEMOGLOBIN DECREASED 336 0.0033
751 PNEUMONITIS 89 0.0033
752 INTENTIONAL PRODUCT MISUSE 286 0.0033
753 INTESTINAL OBSTRUCTION 123 0.0033
754 GASTRIC ULCER 62 0.0033
755 RENAL DISORDER 152 0.0033
756 HYPOPHAGIA 83 0.0032
757 FLUID OVERLOAD 47 0.0032
758 PALPITATIONS 378 0.0032
759 RASH 1395 0.0032
760 HALLUCINATION 241 0.0032
761 EYE DISORDER 105 0.0032
762 POLLAKIURIA 133 0.0032
763 TREATMENT FAILURE 262 0.0032
764 MALAISE 1386 0.0032
765 BLOOD CREATININE INCREASED 206 0.0032
766 CONVULSION 180 0.0031
767 CARDIAC FAILURE CONGESTIVE 252 0.0031
768 DRY EYE 156 0.0031
769 DIARRHOEA 2015 0.0031
770 BLOOD TRIGLYCERIDES INCREASED 55 0.0031
771 PRODUCT USE COMPLAINT 49 0.0031
772 STEVENS-JOHNSON SYNDROME 69 0.0031
773 OFF LABEL USE 2717 0.0031
774 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 149 0.0031
775 DEAFNESS 81 0.0031
776 TOOTH LOSS 64 0.0031
777 EYE HAEMORRHAGE 41 0.0031
778 OSTEONECROSIS OF JAW 76 0.0031
779 CENTRAL NERVOUS SYSTEM LESION 42 0.0031
780 MOBILITY DECREASED 219 0.0030
781 WEIGHT INCREASED 682 0.0030
782 DIALYSIS 43 0.0030
783 PARANOIA 52 0.0030
784 CARDIAC DISORDER 282 0.0030
785 DISTURBANCE IN ATTENTION 162 0.0030
786 PLATELET COUNT DECREASED 320 0.0030
787 SENSORY DISTURBANCE 48 0.0030
788 CONDITION AGGRAVATED 907 0.0030
789 ALANINE AMINOTRANSFERASE INCREASED 183 0.0030
790 HYPERTHYROIDISM 43 0.0030
791 MEMORY IMPAIRMENT 408 0.0030
792 THROMBOCYTOPENIA 331 0.0030
793 IMMUNODEFICIENCY 44 0.0029
794 GENERAL PHYSICAL HEALTH DETERIORATION 340 0.0029
795 FEELING HOT 180 0.0029
796 INSOMNIA 780 0.0029
797 MULTIPLE FRACTURES 48 0.0029
798 OVERDOSE 629 0.0029
799 HAEMORRHAGE 304 0.0029
800 DYSPEPSIA 285 0.0029
801 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 206 0.0029
802 PSYCHOMOTOR HYPERACTIVITY 48 0.0029
803 JOINT SWELLING 349 0.0029
804 MYALGIA 489 0.0029
805 PRURITUS 1105 0.0029
806 HEPATIC CIRRHOSIS 54 0.0029
807 FLUSHING 292 0.0029
808 ORTHOSTATIC HYPOTENSION 50 0.0029
809 NERVOUSNESS 150 0.0029
810 SUBDURAL HAEMATOMA 41 0.0029
811 ANGINA PECTORIS 82 0.0029
812 CARDIAC FAILURE 229 0.0028
813 NEUTROPHIL COUNT DECREASED 116 0.0028
814 PLASMA CELL MYELOMA 110 0.0028
815 FEELING ABNORMAL 675 0.0028
816 RASH PAPULAR 63 0.0028
817 HIP ARTHROPLASTY 43 0.0028
818 IMPAIRED WORK ABILITY 60 0.0028
819 RASH ERYTHEMATOUS 134 0.0028
820 OCULAR HYPERAEMIA 133 0.0028
821 OSTEONECROSIS 92 0.0028
822 PANIC ATTACK 102 0.0028
823 DRUG INEFFECTIVE 3682 0.0028
824 RASH MACULAR 97 0.0028
825 PELVIC PAIN 50 0.0027
826 HYPOCALCAEMIA 52 0.0027
827 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 64 0.0027
828 ABDOMINAL DISCOMFORT 460 0.0027
829 NEUTROPENIA 368 0.0027
830 INCORRECT ROUTE OF DRUG ADMINISTRATION 96 0.0027
831 WHITE BLOOD CELL COUNT DECREASED 291 0.0027
832 EOSINOPHILIA 47 0.0027
833 FOETAL EXPOSURE DURING PREGNANCY 218 0.0027
834 ABDOMINAL PAIN UPPER 549 0.0027
835 FLATULENCE 151 0.0027
836 VISUAL IMPAIRMENT 329 0.0027
837 AGEUSIA 66 0.0026
838 DELUSION 41 0.0026
839 THERAPY INTERRUPTED 188 0.0026
840 PRODUCT PHYSICAL ISSUE 53 0.0026
841 SYSTEMIC LUPUS ERYTHEMATOSUS 93 0.0026
842 TRANSAMINASES INCREASED 58 0.0026
843 HAEMATEMESIS 66 0.0026
844 HOT FLUSH 196 0.0026
845 CEREBRAL HAEMORRHAGE 93 0.0026
846 CEREBROVASCULAR ACCIDENT 440 0.0026
847 MOVEMENT DISORDER 83 0.0026
848 HEPATIC FAILURE 77 0.0026
849 RHEUMATOID ARTHRITIS 289 0.0025
850 LIVER DISORDER 112 0.0025
851 GASTROINTESTINAL HAEMORRHAGE 209 0.0025
852 EYE SWELLING 93 0.0025
853 ADVERSE DRUG REACTION 224 0.0025
854 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 42 0.0025
855 KNEE ARTHROPLASTY 52 0.0025
856 HYPERGLYCAEMIA 90 0.0025
857 THERAPEUTIC RESPONSE UNEXPECTED 110 0.0024
858 SUICIDAL IDEATION 224 0.0024
859 SYNOVITIS 44 0.0024
860 DRUG ERUPTION 43 0.0024
861 FEELING JITTERY 46 0.0024
862 GLOSSODYNIA 54 0.0024
863 THERAPEUTIC PRODUCT EFFECT DECREASED 108 0.0024
864 THIRST 43 0.0024
865 EYE IRRITATION 138 0.0024
866 DEMENTIA 67 0.0024
867 ALOPECIA 470 0.0024
868 NEOPLASM PROGRESSION 83 0.0024
869 INTENTIONAL OVERDOSE 153 0.0024
870 INTERNATIONAL NORMALISED RATIO INCREASED 68 0.0024
871 DYSGEUSIA 176 0.0024
872 CRYING 86 0.0024
873 MIDDLE INSOMNIA 44 0.0024
874 SKIN FISSURES 46 0.0024
875 ISCHAEMIC STROKE 42 0.0024
876 APPLICATION SITE PRURITUS 53 0.0023
877 EPILEPSY 71 0.0023
878 INJECTION SITE SWELLING 177 0.0023
879 DISEASE PROGRESSION 273 0.0023
880 FAECES DISCOLOURED 50 0.0023
881 EMOTIONAL DISORDER 71 0.0023
882 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 42 0.0023
883 BLOOD GLUCOSE DECREASED 110 0.0023
884 HOSPITALISATION 351 0.0023
885 MALIGNANT NEOPLASM PROGRESSION 232 0.0023
886 PROTEINURIA 43 0.0023
887 MUSCULOSKELETAL DISORDER 43 0.0023
888 CHOKING 44 0.0023
889 THINKING ABNORMAL 42 0.0023
890 GASTRIC DISORDER 77 0.0022
891 TYPE 2 DIABETES MELLITUS 75 0.0022
892 PRESCRIBED OVERDOSE 43 0.0022
893 ABDOMINAL PAIN LOWER 56 0.0022
894 PSORIATIC ARTHROPATHY 89 0.0022
895 WITHDRAWAL SYNDROME 92 0.0022
896 INJECTION SITE MASS 81 0.0022
897 RHABDOMYOLYSIS 91 0.0022
898 PSYCHOTIC DISORDER 64 0.0022
899 HYPOGLYCAEMIA 105 0.0022
900 LACTIC ACIDOSIS 70 0.0022
901 SKIN IRRITATION 99 0.0022
902 HYPOACUSIS 93 0.0022
903 SKIN EXFOLIATION 182 0.0022
904 BLOOD CREATINE PHOSPHOKINASE INCREASED 62 0.0022
905 ECZEMA 112 0.0021
906 MELAENA 47 0.0021
907 THERAPEUTIC RESPONSE DECREASED 128 0.0021
908 HAEMATOCHEZIA 116 0.0021
909 DEPRESSED MOOD 111 0.0021
910 HEPATIC ENZYME INCREASED 141 0.0021
911 COMPLICATION OF DEVICE INSERTION 41 0.0021
912 NEOPLASM MALIGNANT 137 0.0021
913 DEVICE DISLOCATION 88 0.0020
914 THERAPEUTIC RESPONSE SHORTENED 67 0.0020
915 INJECTION SITE PRURITUS 135 0.0020
916 LABORATORY TEST ABNORMAL 59 0.0020
917 DEATH 1719 0.0020
918 INJECTION SITE PAIN 612 0.0020
919 TREATMENT NONCOMPLIANCE 109 0.0020
920 PANCREATITIS 105 0.0020
921 MOOD ALTERED 54 0.0020
922 EXTRAPYRAMIDAL DISORDER 49 0.0020
923 CARDIOVASCULAR DISORDER 50 0.0020
924 RASH GENERALISED 51 0.0020
925 NIGHTMARE 68 0.0020
926 CEREBRAL INFARCTION 48 0.0020
927 INJECTION SITE ERYTHEMA 239 0.0019
928 ILL-DEFINED DISORDER 117 0.0019
929 FREQUENT BOWEL MOVEMENTS 52 0.0019
930 IRRITABILITY 115 0.0019
931 LEUKOPENIA 95 0.0019
932 AGGRESSION 95 0.0019
933 EXPIRED PRODUCT ADMINISTERED 63 0.0019
934 PRODUCT DOSE OMISSION 120 0.0018
935 INJECTION SITE BRUISING 145 0.0018
936 EYE PRURITUS 61 0.0018
937 DRY SKIN 240 0.0018
938 DRUG ADMINISTRATION ERROR 55 0.0018
939 DRUG EFFECT INCOMPLETE 65 0.0018
940 HEPATIC FUNCTION ABNORMAL 66 0.0018
941 WRONG TECHNIQUE IN DRUG USAGE PROCESS 64 0.0018
942 LIVER INJURY 43 0.0018
943 CONTRAINDICATED PRODUCT ADMINISTERED 53 0.0017
944 INJECTION SITE REACTION 120 0.0017
945 MYOCARDIAL INFARCTION 302 0.0017
946 MULTIPLE SCLEROSIS 82 0.0017
947 NO ADVERSE EVENT 310 0.0017
948 DRUG EFFECT DECREASED 92 0.0017
949 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 50 0.0017
950 INCORRECT DOSE ADMINISTERED 383 0.0017
951 DEVICE ISSUE 150 0.0017
952 VAGINAL HAEMORRHAGE 72 0.0017
953 FEMUR FRACTURE 51 0.0016
954 HEPATITIS 42 0.0016
955 PAIN OF SKIN 44 0.0016
956 COMPLETED SUICIDE 132 0.0016
957 ACCIDENTAL EXPOSURE TO PRODUCT 161 0.0016
958 ADVERSE EVENT 143 0.0016
959 ABNORMAL BEHAVIOUR 60 0.0015
960 INTERSTITIAL LUNG DISEASE 73 0.0015
961 BLOOD GLUCOSE INCREASED 279 0.0015
962 DEVICE LEAKAGE 64 0.0015
963 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 298 0.0015
964 SUICIDE ATTEMPT 88 0.0014
965 ABNORMAL DREAMS 40 0.0014
966 LIVER FUNCTION TEST ABNORMAL 42 0.0014
967 DRUG-INDUCED LIVER INJURY 45 0.0014
968 PRODUCT SUBSTITUTION ISSUE 80 0.0014
969 MULTIPLE SCLEROSIS RELAPSE 93 0.0014
970 DRUG EXPOSURE DURING PREGNANCY 45 0.0013
971 DRUG WITHDRAWAL SYNDROME 112 0.0013
972 DISEASE RECURRENCE 59 0.0012
973 THERAPY CESSATION 63 0.0012
974 DEVICE BREAKAGE 49 0.0012
975 INJECTION SITE HAEMORRHAGE 96 0.0012
976 EXTRA DOSE ADMINISTERED 48 0.0012
977 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 40 0.0012
978 ANGER 40 0.0012
979 PSORIASIS 152 0.0012
980 COLITIS ULCERATIVE 50 0.0011
981 DEVICE MALFUNCTION 78 0.0011
982 LUNG NEOPLASM MALIGNANT 45 0.0011
983 DERMATITIS ATOPIC 57 0.0011
984 DRUG DEPENDENCE 170 0.0011
985 SKIN BURNING SENSATION 75 0.0010
986 ACNE 72 0.0009
987 DRUG DOSE OMISSION 154 0.0009
988 BREAST CANCER 84 0.0009
989 UNDERDOSE 63 0.0009
990 DEVICE DIFFICULT TO USE 56 0.0008
991 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 52 0.0007
992 PRODUCT STORAGE ERROR 61 0.0007